NIPRO

Our BusinessRegenerative Medicine Business

Creating the future with regenerative medicine

We contribute to the development of regenerative medicine, including autologous bone-marrow mesenchymal stem cells. This is the world’s first regenerative medicine product that has been approved for manufacturing and marketing (with conditions and time limits) for use in the treatment of patients with traumatic spinal cord injury.

Autologous bone-marrow
mesenchymal stem cells

A regenerative medicine product made from the patient’s own bone marrow fluid and blood. It is intended to be used in patients with traumatic spinal cord injury during the acute phase, for the purpose of improving neurological symptoms and paralyzed motor functions associated with spinal cord injury.

Culture products

Culture media and culture products are indispensable for cell proliferation and differentiation. These products contribute to safe and reliable research and development by manufacturing with the same quality as pharmaceuticals and medical devices.*Reserch use only.

Cell preservation products

Cryopreservation containers for long-term preservation of cultured cells and related reagents.

The products on the English website may not be available locally. Detail of intended purpose may also vary by local.
Please contact with our local representative in more detail.

Our Business